الولايات المتحدة · منصات وبيانات · Yahoo Finance

Oculis to Present Late-Breaking Phase 2 ACUITY Biomarker Analyses of Privosegtor in Optic Neuritis at the 10th Joint ACTRIMS-ECTRIMS Meeting

نشره Yahoo Finance · الولايات المتحدة منذ 8 س

The presentation will provide congress attendees, clinical investigators, members of the neuro-ophthalmology and multiple sclerosis communities with an opportunity to hear…

اقرأ المقال كاملًا على Yahoo Finance سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (finance.yahoo.com)

يستحق القراءة أيضًا

The Motley Fool

Oculis to Present Late-Breaking Phase 2 ACUITY Biomarker Analyses of Privosegtor in Optic Neuritis at the 10th Joint ACTRIMS-ECTRIMS Meeting

مشاركة

يستحق القراءة أيضًا

Prediction: These 3 Stocks Will 10X in the Next 20 Years

The AES Corporation (NYSE:AES) Stock Has Consensus Target Price of $15.83

Nvidia to back four German AI startups as part of near-$10B European push

The world’s finance chiefs see new risks — and less China angst

Peloton COO Kirol sells $153,765 of company stock

Japan's 20-Year Government Bond Auction Draws Record Demand